Medi-Span Electronic Drug Database
ID: SP-HI-333245Type: Combined Synopsis/Solicitation
Overview

Buyer

OFFICE OF PERSONNEL MANAGEMENTOFFICE OF PERSONNEL MANAGEMENTOPM DC CENTRAL OFFICE CONTRACTINGWASHINGTON, DC, 20415, USA

NAICS

All Other Publishers (513199)

PSC

IT AND TELECOM - BUSINESS APPLICATION SOFTWARE (PERPETUAL LICENSE SOFTWARE) (7A21)

Original Source

https://sam.gov/opp/e1198d2234ad4f999d68b8bc7d3ea525/view
Timeline
    Description

    The U.S. Office of Personnel Management (OPM) is seeking proposals for the renewal of the Medi-Span Electronic Drug Database to support its Healthcare and Insurance program office. This procurement is based on Brand Name requirements, specifically targeting MediSpan/UpToDate as the preferred provider, under NAICS code 513199. The contract will cover a base period from September 30, 2024, to September 29, 2025, with four additional option periods extending through September 29, 2029. Proposals must be submitted by September 11, 2024, and should include fixed prices for all items listed in the Bill of Materials. Interested parties can contact Erica Randall at erica.randall@opm.gov or Carrie Fairbanks at carrie.fairbanks@opm.gov for further information.

    Point(s) of Contact
    Erica Randall
    erica.randall@opm.gov
    Carrie Fairbanks
    carrie.fairbanks@opm.gov
    Files
    Title
    Posted
    OPM RFQ_333245 - MediSpan.pdf
    The Request for Quotation (RFQ) issued by the Office of Personnel Management (OPM) aims to procure the MediSpan Electronic Drug File for its Healthcare & Insurance Office. This RFQ is based on Brand Name requirements, specifying MediSpan/UpToDate as the preferred provider under NAICS code 513199. The contract will cover a base period from September 30, 2024, to September 29, 2025, with four additional option periods extending until September 29, 2029. Proposals must be submitted by September 11, 2024, and should include fixed prices for all items listed in the Bill of Materials (BOM). Evaluation factors for award focus on technical capability and price, with quotes being assessed on their adherence to the requirements in the BOM. The RFQ emphasizes the importance of a firm-fixed price, and all quotations must be in English and U.S. dollars. The document details various provisions, including commitments of public funds and communication protocols prior to award, underscoring the structured nature of federal procurement processes aimed at maintaining fairness and transparency.
    Lifecycle
    Title
    Type
    Medi-Span Electronic Drug Database
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    PHARMACY BENEFITS MANAGEMENT SERVICES (PBM)
    Active
    Labor, Department Of
    The Department of Labor plans to contract Pharmacy Benefits Management Services (PBM) for its Office of Workers' Compensation (OWCP). The upcoming Request for Proposal (RFP) seeks a single Fixed Price contract for comprehensive PBM services, including prescription coverage and a pharmacy card system for OWCP's various divisions. Important dates have yet to be announced. Interested parties should monitor the situation closely, as direct contact with the Contracting Officer is prohibited.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Active
    Dept Of Defense
    The Department of Defense (DoD) is issuing a Request for Quotation (RFQ) for the establishment of Blanket Purchase Agreements (BPA) and Additional Discount Program (ADP) agreements related to pharmaceutical agents under the Defense Health Agency's Uniform Formulary (UF). This procurement aims to secure pricing agreements for various newly approved drugs, including those in the classes of Parkinson's agents, gastrointestinal agents, respiratory agents, hematological agents, targeted immunomodulatory biologics, anticonvulsants, and oncological agents, which will be reviewed during the Pharmacy and Therapeutics (P&T) Committee meeting scheduled for November 6-7, 2024. The initiative is crucial for maintaining an effective pharmacy benefits program for the Military Health System (MHS), ensuring that military personnel have access to high-value medications while adhering to cost-effectiveness criteria. Interested manufacturers must submit their quotes by September 19, 2024, and can direct inquiries to primary contact Stephanie Erpelding at stephanie.j.erpelding.civ@health.mil or secondary contact Tracy Banks at tracy.e.banks2.civ@health.mil.
    Subscription to news, schedules, federal budget and appropriations
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking to procure subscriptions to Budget Tracker for six individuals, aimed at enhancing legislative tracking and budget monitoring capabilities. The procurement includes a base year subscription with options for four additional years, providing essential documents related to appropriation bills, detailed bill status charts, and legislative analysis. These subscriptions are critical for the FDA's Office of Regulatory Affairs to maintain continuous access to vital financial and legislative information, particularly during periods of congressional delays in finalizing appropriations. Interested vendors should contact Valrica Manns at valrica.manns@fda.hhs.gov or call 301-837-7507 for further details, with the anticipated period of performance extending from August 2024 to August 2029.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Active
    Dept Of Defense
    The Department of Defense (DoD) is soliciting quotations for pharmaceutical agents under the Pharmacy Uniform Formulary Blanket Purchase Agreement and the Uniform Formulary Additional Discount Program, aimed at enhancing the Military Health System's pharmacy benefits. This procurement process is governed by 10 U.S.C. § 1074g and involves the evaluation of pharmaceutical agents based on their clinical and cost-effectiveness, with a focus on specific drug classes such as Oral CGRP migraine agents and Interleukin 17 and 23 targeted immunomodulatory biologics. Interested manufacturers must submit their quotes by September 19, 2024, following a pre-quotation teleconference scheduled for July 24, 2024, and can direct inquiries to primary contacts Stephanie Erpelding and Tracy Banks via their provided emails.
    FDA Library Digital Subscription Services and Support
    Active
    Health And Human Services, Department Of
    The Food and Drug Administration (FDA) is seeking qualified vendors to provide digital subscription services and support for its library resources, aimed at enhancing access to credible scientific information for its staff. The procurement involves establishing a Blanket Purchase Agreement that consolidates subscription management, covering renewals and purchases of journals, databases, and training materials, while ensuring these resources are accessible through a secure online tracking system. This initiative is crucial for maintaining an extensive and well-managed library that supports the FDA's public health mission, ensuring reliable access to critical information for its employees. Interested vendors should submit their capabilities statements by September 23, 2024, to Vivianna Diaz at Vivianna.Diaz@fda.hhs.gov, with a total funding allowance of $450,000 for unforeseen subscription changes over the contract period from January 1, 2025, to January 31, 2030.
    Repaglinide
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Repaglinide Tablets. The contract will establish a national supply source for the purchase of Repaglinide 0.5MG, 1MG, and 2MG in 100 count bottles. This acquisition will be unrestricted and fully competitive. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The items listed in the schedule will be purchased by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. Interested parties should contact Phyllis Daraio for any questions/comments. The projected solicitation date is September 2020.
    8145--Medication Return Envelopes (VA-24-00012799)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Medication Return Envelopes under solicitation number 36C77024Q0051. This initiative aims to supply multiple Veterans Affairs Medical Centers (VAMCs) and Consolidated Mail Outpatient Pharmacies (CMOP) with a system for the safe disposal of scheduled and non-controlled medications over a five-year period, from November 2024 to October 2029. The program is critical for enhancing medication safety, preventing accidental overdoses, and reducing environmental waste, with an estimated budget of $47 million. Interested vendors must submit their bids by October 14, 2024, at 5 PM Central Time, and are encouraged to monitor SAM.gov for further solicitation details, which will be posted on September 13, 2024. For inquiries, contact Contract Specialist Diana Olson at Diana.Olson@va.gov or 913-684-0153.
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking proposals for the preparation and distribution of research drug products under a presolicitation notice. The contract will involve acquiring, importing, and exporting drugs and chemical compounds, as well as developing and analyzing various drug dosage forms, including marijuana and nicotine research cigarettes, to support drug abuse and addiction research. This contract is critical for maintaining a reliable supply of authentic controlled and uncontrolled drug compounds for the research community, with an anticipated award of one indefinite delivery, indefinite quantity (IDIQ) contract over a five-year period. Interested parties must possess a current DEA registration and comply with FDA’s current Good Manufacturing Practices, with proposals due approximately 45 days after the release of the RFP, expected on or about September 20, 2024. For further inquiries, contact Scott Duernberger at scott.duernberger@nih.gov or 301-594-0670.
    6505--760_Pharmaceuticals_VA CMOP Leavenworth_36C77024Q0344
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is announcing a special notice regarding the awarding of contracts under Solicitation Number 36C77024Q0344, specifically for pharmaceutical services through the National CMOP Contracting Office. This procurement has resulted in two awards totaling $157,961.04, granted to Core Trading Company and Pharmacy Buying Association, Inc., for various line items related to pharmaceutical preparation. The awarded contracts are part of the government's ongoing efforts to efficiently procure necessary pharmaceutical services for veterans. Interested parties should contact Contracting Specialist Jeffrey Blackard at jeffrey.blackard@va.gov or call 913-684-1042, with submissions due by September 18, 2024, at 10 PM Central Time.
    Comprehensive Medical Services - FCC Lompoc
    Active
    Justice, Department Of
    The U.S. Department of Justice, Federal Bureau of Prisons is seeking proposals for comprehensive medical services at the Federal Correctional Complex (FCC) in Lompoc, California. The goal is to contract these services for a base year, with the possibility of four extensions, each under a firm-fixed-price agreement. The scope of work involves managing and staffing the medical care facility to provide a comprehensive range of services, including primary care, specialty services, dental care, and emergency response. The awardee will also be responsible for administrative tasks, record-keeping, and medication management, in addition to coordinating mental health services with other healthcare providers. Successful bidders will need to demonstrate their ability to recruit and retain a qualified medical staff, as detailed in the solicitation. This includes having licensed medical professionals and meeting specified staffing ratios. The contract encompasses several key clauses related to indemnification, insurance, and privacy. The evaluation of proposals will consider the quality of services, staff qualifications, past performance, and price, with the former three being leading factors. To apply, vendors must submit their proposals by the deadline on October 1st, 2024, at 2:00 PM local time. For any clarifications or questions, interested parties can contact LaShundra D. Thomas at ldthomas@bop.gov or via phone at 202-598-6077.